Stay updated on Roxadustat for Anemia in ESRD Dialysis Patients Clinical Trial
Sign up to get notified when there's something new on the Roxadustat for Anemia in ESRD Dialysis Patients Clinical Trial page.

Latest updates to the Roxadustat for Anemia in ESRD Dialysis Patients Clinical Trial page
- Check5 days agoChange DetectedThe Roxadustat anemia study record is now displayed instead of a 403 error page, with its study design, participant criteria, outcome measures, locations, and supporting documents available.SummaryDifference100%

- Check12 days agoChange DetectedThe study page no longer shows the 403 Forbidden message or its Home button, and the main content area appears blank.SummaryDifference0.5%

- Check19 days agoChange DetectedThe footer’s site revision changed from v3.7.2 to v3.8.0; the page still displays a 403 error instead of the study record.SummaryDifference0.2%

- Check26 days agoChange DetectedA site-wide notice announces NIH’s transition from “Artificial Intelligence” to “Super Intelligence” terminology. It appears above the unavailable study record.SummaryDifference1%

- Check33 days agoChange DetectedThe footer revision identifier changed from v3.7.1 to v3.7.2; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check40 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the page continues to show a 403 Forbidden error.SummaryDifference0.2%

Stay in the know with updates to Roxadustat for Anemia in ESRD Dialysis Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Roxadustat for Anemia in ESRD Dialysis Patients Clinical Trial page.